Daly City, CA, United States of America

David H Lloyd


Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 579(Granted Patents)


Location History:

  • San Francisco, CA (US) (1994)
  • Daly City, CA (US) (1995 - 2000)

Company Filing History:


Years Active: 1994-2000

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David H. Lloyd

Introduction

David H. Lloyd is a prominent inventor based in Daly City, California. He holds a total of seven patents, showcasing his significant contributions to the field of biotechnology. His work primarily focuses on the development of oligonucleotide-based technologies with diagnostic and therapeutic applications.

Latest Patents

One of his latest patents is titled "Oligonucleotide clamps having diagnostic and therapeutic applications." This invention provides compounds known as oligonucleotide clamps that stably bind to target polynucleotides in a sequence-specific manner. The clamps consist of one or more oligonucleotide moieties capable of specifically binding to a target polynucleotide, along with pairs of binding moieties covalently linked to the oligonucleotide moieties. Upon annealing, the binding moieties form a stable complex with the target polynucleotide, effectively clamping the oligonucleotide moieties in place.

Another significant patent is "Massively parallel signature sequencing by ligation of encoded adaptors." This invention outlines a method for nucleic acid sequence analysis that involves the ligation of encoded adaptors to the terminus of a target polynucleotide. The encoded adaptors form perfectly matched duplexes with the target, allowing for the determination of nucleotide identity through a labeled tag carried by the adaptor.

Career Highlights

Throughout his career, David H. Lloyd has worked with notable companies such as Lynx Therapeutics, Inc. and Applied Biosystems, LLC. His experience in these organizations has contributed to his expertise in the field of molecular biology and biotechnology.

Collaborations

David has collaborated with esteemed colleagues, including Sergei M. Gryaznov and Robert J. DeFranco. These collaborations have further enriched his research and innovations in the biotechnology sector.

Conclusion

David H. Lloyd's innovative work in oligonucleotide technology has made a significant impact in the field of biotechnology. His patents reflect his dedication to advancing diagnostic and therapeutic applications, showcasing his role as a leading inventor in this domain.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…